• By ICR Secretariat
  • Posted Friday, January 25, 2019

7 biopharma trends to watch in 2019


Bristol-Myers Squibb's splashy $74 billion Celgene buy is set to reset the top ranks of pharma, but the industry's year ahead will be shaped more directly by larger trends impacting the sector's perception, investment and future growth.